Clinical Trial Update: Evaluate Immunogenicity, Safety, and Reactogenicity of Rotavac in Healthy Infants in Vietnam [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating immunogenicity, safety, and reactogenicity of Rotavac in healthy infants in Vietnam for rotavirus gastroenteritis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rotavirus Gastroenteritis

Drugs mentioned

• Rotavac

Snippet

Sponsor: Bharat Biotech International Limited | Conditions: Rotavirus Gastroenteritis | Phase 3 | Status: COMPLETED